AnjuNohriaMD
Cardiology • Boston, MAAdult Congenital Heart Disease, Heart Failure & Transplantation
Assistant Professor of Medicine, Brigham and Women's Hospital
Dr. Nohria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Pbb-1, Room 364
Boston, MA 02115Phone+1 617-525-7052Fax+1 617-264-5265
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1998 - 2001
Yale-New Haven Medical CenterResidency, Internal Medicine, 1994 - 1997
Harvard Medical SchoolClass of 1994
Certifications & Licensure
FL State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
MA State Medical License 2000 - 2025
ME State Medical License 2011 - 2024
NH State Medical License 2022 - 2024
CT State Medical License 1997 - 1998- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction Start of enrollment: 2003 Apr 01
- Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis Start of enrollment: 2008 Mar 13
- Inflammation and Vascular Function in Atherosclerosis Start of enrollment: 2005 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 930 citationsMYOCARDITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORSSyed S. Mahmood, Michael G. Fradley, Justine V. Cohen, Anju Nohria, Kerry L. Reynolds
Journal of the American College of Cardiology. 2018-04-24 - 206 citationsCardiovascular magnetic resonance in immune checkpoint inhibitor-Associated myocarditisLili Zhang, Magid Awadalla, Syed S. Mahmood, Anju Nohria, Malek Z.O. Hassan
European Heart Journal. 2020-05-07 - 67 citationsDefining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.Joerg Herrmann, Daniel Lenihan, Saro Armenian, Ana Barac, Anne Blaes
European Heart Journal. 2022-01-31
Authored Content
- Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir in Patients with COVID-19: JACC Review Topic of the WeekOctober 2022
Press Mentions
Research Letter Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint InhibitorsMarch 16th, 2021
Development and Implementation of an Online Adaptive SBRT Workflow for Treatment of Intracardiac MetastasisFebruary 5th, 2021- Screenings for Cardiac Dysfunction Among Childhood Cancer Survivors Can Be More Precisely TailoredAugust 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
